Established in 1982, Mastek is a provider of vertically-focused enterprise technology solutions. Having its presence in IT industry for almost 4 decades, Mastek Ltd has evolved from an IT solutions provider to Digital transformation partner.
Q3 FY26 Earnings Results
- Revenue from Operations: ₹905.7 crore, down 3.7% QoQ from ₹940.4 crore in Q2 FY26, up 4.2% YoY from ₹869.5 crore in Q3 FY25.
- Total Income: ₹926.6 crore, down 3.0% QoQ, up 5.4% YoY.
- Operating EBITDA: ₹145.6 crore, up ~6% QoQ from ₹145.5 crore; operating EBITDA margin 16.1%, up 60 bps QoQ from 15.5%.
- Net Profit (PAT): ₹108.4 crore, up 11.2% QoQ from ₹97.5 crore, up 14.4% YoY from ₹94.7 crore.
- PBT margin: 15.6%, up from 14.2% in Q2 FY26.
- EPS (basic): ₹34.97, up 11.1% QoQ, up 13.9% YoY.
- 9M FY26 performance:
- Revenue from Operations: ₹2,760.8 crore, up 8.3% YoY.
- Total Income: ₹2,807.3 crore, up 9.3% YoY.
- Net Profit: ₹2,978.5 crore, up ~1% YoY from ₹2,948.6 crore.
- Basic EPS: ₹96.2 vs ₹95.55 in 9M FY25.
Management Commentary & Strategic Decisions – Q3 FY26
- Management described Q3 FY26 as a resilient quarter with sequential profitability improvement and margin expansion, despite revenue softness due to seasonal factors and execution timing; AI‑led deals (26+ new) and strong UK/Europe performance offset North America and AMEA weakness.
- CEO Umang Nahata highlighted operational discipline, AI strategy execution and 12‑month order backlog growth of 7.0% QoQ to ₹2,484 crore, with a robust pipeline across healthcare, public sector and government services.
- Strategic focus areas:
- Scaling AI‑led digital transformation services, with over 25 new AI deals in Q3 and active engagement in healthcare ecosystem globally.
- Strengthening core markets (UK & Europe at 64.5% of revenue) while rebuilding traction in North America (22.6%) and AMEA (12.9%).
- Dividend: Declared ₹8 per share interim dividend (160%), payable by Feb 17, 2026 (record date Jan 30); reflecting strong cash generation.
Q2 FY26 Earnings Results
- Revenue from Operations: ₹940.4 crore, up 8.4% YoY from ₹867.4 crore, up 2.8% QoQ from ₹914.7 crore in Q1 FY26.
- Operating EBITDA: ₹145.5 crore, up 6% QoQ; EBITDA margin 15.5% vs 15.0% in Q1 FY26 (down from 16.5% YoY).
- Net Profit (PAT): ₹97.5 crore, down 24.3% YoY from ₹128.7 crore, up 5.9% QoQ from ₹91.5 crore.
- Order backlog: 12‑month backlog ₹2,484.3 crore, up 13.2% YoY.
- Regional mix: UK & Europe 64.5%, North America 22.6%, AMEA 12.9%.
Management Commentary & Strategic Directions – Q2 FY26
- CEO Umang Nahata emphasised resilience through AI‑led digital transformation strategy and renewed healthcare/public sector traction, with strong UK/Europe execution offsetting other regions.
- Management confidence in FY26 high single‑digit revenue growth and 15–17% EBITDA margins sustained through operational efficiency and AI investments.
To view the company’s previous earnings and latest concall transcripts, click here to visit the Alphastreet India news channel.